AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection.
about
Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectorsAdeno-associated virus type 2-mediated gene transfer: role of cellular FKBP52 protein in transgene expressionPackaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps.The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectorsCell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells.Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminusCross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroupsDifferential activation of innate immune responses by adenovirus and adeno-associated virus vectorsAdeno-associated Virus as a Mammalian DNA VectorAdeno-associated virus for cystic fibrosis gene therapyLearning from the Viral Journey: How to Enter Cells and How to Overcome Intracellular Barriers to Reach the NucleusVaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycansAdeno-associated virus: from defective virus to effective vectorIdentification of a glycosaminoglycan binding region of the alpha C protein that mediates entry of group B Streptococci into host cellsThe structure of adeno-associated virus serotype 3B (AAV-3B): Insights into receptor binding and immune evasionElectron microscopy analysis of a disaccharide analog complex reveals receptor interactions of adeno-associated virusRecombinant adeno-associated viral (rAAV) vectors mediate efficient gene transduction in cultured neonatal and adult microgliaBAAV transcytosis requires an interaction with beta-1-4 linked- glucosamine and gp96Methods, potentials, and limitations of gene delivery to regenerate central nervous system cellsStructure of neurotropic adeno-associated virus AAVrh.8.The structure of human parvovirus B19Adeno-associated virus vector mediated gene transfer to pancreatic beta cells.Adeno-associated virus serotype 9 administered systemically after reperfusion preferentially targets cardiomyocytes in the infarct border zone with pharmacodynamics suitable for the attenuation of left ventricular remodeling.Plectin-1 Targeted AAV Vector for the Molecular Imaging of Pancreatic Cancer.Adeno-associated virus-mediated gene delivery into the scala media of the normal and deafened adult mouse ear.A muscle-targeting peptide displayed on AAV2 improves muscle tropism on systemic delivery.Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transduction.Cytoplasmic trafficking, endosomal escape, and perinuclear accumulation of adeno-associated virus type 2 particles are facilitated by microtubule network.Comparative analysis of adeno-associated virus capsid stability and dynamicsIntegrins and integrin-associated proteins in the cardiac myocyte.Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infectionIntegrin alpha3beta1 is an alternative cellular receptor for adenovirus serotype 5Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transferEngineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles.Application of a haematopoetic progenitor cell-targeted adeno-associated viral (AAV) vector established by selection of an AAV random peptide library on a leukaemia cell line.Tropism-modified AAV vectors overcome barriers to successful cutaneous therapy.Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation.An adeno-associated viral vector transduces the rat hypothalamus and amygdala more efficient than a lentiviral vector
P2860
Q24515072-7FC89A60-75C2-4F10-A609-0F58531A781BQ24529153-833F458D-E04F-4E26-8F6E-FB27A152BD78Q24529167-ABAEB3CF-81F7-4791-A92B-8770047F01F9Q24533013-15EEC68A-C98F-43F7-88A0-3D24A241ED8CQ24533492-69BEB733-96FD-45C3-A583-99EC46B61C38Q24538483-E682A733-DE80-4427-8DF6-ECD982788120Q24538924-C6413385-BE95-449B-A57D-E12790E95778Q24563214-F3979248-93EB-4FBE-B4D9-F36B067952E3Q24623923-3AA9E241-959F-4D98-8D4E-A5AECA73BC0CQ24673796-AF3249EB-0A1F-4CE7-A7F9-6CD0D7BCFAA0Q26782605-40204980-D88C-438B-BB62-B15790F9AE6FQ26823156-F57D005D-AC5D-4455-BED2-14D94ACB04B4Q27488284-BA889BA8-BBCF-4D9A-ACE3-90787F25A61FQ27488704-8CE51D57-211C-4A55-B3CD-298D8DAD2D23Q27498163-2707C216-5203-43BB-BB7C-3A6717247DBAQ27643681-288F4A42-EA03-40AC-BB20-939523BD6007Q27661320-E9D69F47-0871-43F3-9DFD-26C92A6ECBB0Q27679952-9269181D-D578-4781-A227-7A619A2B966DQ28386583-32190182-8B83-4174-832C-19819749BC07Q28748622-5719620A-EB85-4718-802B-06AE5C065E0DQ28766660-F57ADA49-AB07-4E7B-B386-060B16436440Q30152836-2C73C7B9-E2FA-450E-AA38-260DA642F9A6Q30163895-05467782-08B3-4481-80DD-9EB4912BCEA5Q30306214-7EF426FB-B1B8-424C-951A-770AC1CF52AFQ30417445-BF467001-6CE0-4BE2-B657-0B36978520E6Q30419813-29EF9476-0098-4C12-8F4D-EC0C46ACDAB7Q30472510-8ED03597-7803-418B-9215-4AD476722368Q30483589-DEB67E98-714A-456E-B871-74DB35B80C25Q30495947-0C817D31-A005-4431-B2EB-AACFD5C42B08Q30525258-3C35D377-57E1-4D79-B535-98866331E4A2Q30557598-83A2C2DB-27F7-4E67-BA4A-9B3A799DF81EQ30575418-672C411C-4C72-4CFE-93FB-1E0C20497A72Q30923081-F7146C95-04BA-4D71-9349-38E88815373EQ33195467-778B4BE6-2957-485F-A8E9-6660A1C2BC4BQ33296224-FBE0DC4C-A505-4BD0-B6F8-B91D2AB44D0CQ33337378-41177360-D404-49CF-910A-EED0CC37238BQ33369214-3566EA7A-3615-438E-8C8F-1EB119A47399Q33587005-2D934430-F212-41E2-B14F-79C2080C2BA5Q33604753-8E58C69C-7F5C-403C-99EA-233052BC1D16Q33631705-289380ED-89A9-498F-8368-1F7A12AA8E2D
P2860
AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection.
@ast
AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection.
@en
AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection.
@nl
type
label
AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection.
@ast
AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection.
@en
AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection.
@nl
prefLabel
AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection.
@ast
AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection.
@en
AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection.
@nl
P2093
P356
P1433
P1476
AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection.
@en
P2093
Bartlett JS
Samulski RJ
Summerford C
P2888
P356
10.1038/4768
P407
P577
1999-01-01T00:00:00Z